Author details

Full Name

David Kozono

Affiliation

ORCID

Career Start Year

1999

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36780674	Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.	N Engl J Med	2023
38030080	Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART).		2023
37150319	Association of Patient Experience of Care and Radiation Therapy Initiation Among Women With Early-Stage Breast Cancer.		2023
37274244	Radiation-induced circulating microRNAs linked to echocardiography parameters after radiotherapy.		2023
37121537	Surgical management of non-small cell lung cancer with limited metastatic disease involving only the brain.		2023
37311043	Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer.	Stem Cells Transl Med	2023
37368273	Smart Radiotherapy Biomaterials for Image-Guided In Situ Cancer Vaccination.		2023
37301262	Serum miRNA-based signature indicates radiation exposure and dose in humans: A multicenter diagnostic biomarker study.	Radiother Oncol	2023
37235847	Natural Language Processing Methods to Empirically Explore Social Contexts and Needs in Cancer Patient Notes.	JCO Clin Cancer Inform	2023
35084935	Elevated Coronary Artery Calcium Quantified by a Validated Deep Learning Model From Lung Cancer Radiotherapy Planning Scans Predicts Mortality.	JCO Clin Cancer Inform	2022
35972384	Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers.	Cancer Res	2022
36028289	Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study.	Lancet Digit Health	2022
35613998	Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer.	Clinical Lung Cancer	2022
35297944	Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).	JAMA Oncol	2022
34774998	Dosimetric Planning Tradeoffs to Reduce Heart Dose Using Machine Learning-Guided Decision Support Software in Patients with Lung Cancer.	Int J Radiat Oncol Biol Phys	2022
35089673	The clinician's guide to radiotherapy complications.	Polish Archives of Internal Medicine	2022
34527708	Radiation Induces Valvular Interstitial Cell Calcific Response in an Model of Calcific Aortic Valve Disease.	Frontiers in Cardiovascular Medicine	2021
33476841	Statin Use, Heart Radiation Dose, and Survival in Locally Advanced Lung Cancer.	Pract Radiat Oncol	2021
34052704	Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ.	Lung Cancer	2021
33878954	Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO).	Immunotherapy	2021
33657372	MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity.	Cell Rep	2021
33713743	Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy.	Int J Radiat Oncol Biol Phys	2021
34311345	Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer.	Lung Cancer	2021
33331883	Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer.	JAMA Oncol	2021
34590049	Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.	JTO Clin Res Rep	2021
34695520	Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy.	Radiotherapy and Oncology	2021
33108758	CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress.	Mol Cell	2020
32075772	Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection.	Cell Rep	2020
31937336	The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer.	Radiat Oncol	2020
32273495	Author Correction: Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models.	Nature Communications	2020
33305087	Phase I/II Study of Stereotactic Body Radiation Therapy for Pulmonary Metastases in Pediatric Patients.	Advances in Radiation Oncology	2020
32731132	Increased carcinoembryonic antigen expression on the surface of lung cancer cells using gold nanoparticles during radiotherapy.	Physica Medica	2020
30991100	Lipopolysaccharide-Binding Protein Is an Early Biomarker of Cardiac Function After Radiation Therapy for Breast Cancer.	International Journal of Radiation Oncology Biology Physics	2019
30559380	Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.	Nature	2019
31341973	EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis.	Clinical and Translational Radiation Oncology	2019
31196455	Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With LungÂ Cancer.	J Am Coll Cardiol	2019
27819875	Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection.	Am J Clin Oncol	2018
35135121	Outcomes by <i>EGFR</i>, <i>KRAS</i>, and <i>ALK</i> Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.	JCO Precis Oncol	2018
28941581	Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy.	Journal of Geriatric Oncology	2018
30576655	USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors.	Mol Cell	2018
29531807	NF-ÎºB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair.	Cell Death Discov	2018
29760046	Dual HDAC and PI3K Inhibition Abrogates NFÎºB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.	Cancer Res	2018
27709803	Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.	J Med Imaging Radiat Oncol	2017
28426673	Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC.	PLoS One	2017
29102264	Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques.	Radiotherapy and Oncology	2017
27987576	Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC.	Lung Cancer	2016
27053300	TGF-Î² Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia.	Cell Stem Cell	2016
27133748	Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.	Lung Cancer	2016
27264184	FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair.	Cell Rep	2016
27117590	Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.	Radiat Oncol	2016